Elevated levels of circulating tumor necrosis factor-α, interferon-γ, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis
- 31 May 1991
- Vol. 3 (3) , 266-267
- https://doi.org/10.1016/1043-4666(91)90026-a
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Neurotoxicity after Treatment with Muromonab-CD3New England Journal of Medicine, 1990
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1989
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985